Endothelin B receptor-deficient rats as a subtraction model to study the cerebral endothelin system-Reference-Cited by-同舟云学术

Endothelin B receptor-deficient rats as a subtraction model to study the cerebral endothelin system

Published:1999-07 Issue:3 Volume:91 Page:1067-1075
ISSN:0306-4522
Container-title:Neuroscience
language:en
Short-container-title:Neuroscience

Author:

Ehrenreich H,Oldenburg J,Hasselblatt M,Herms J,Dembowski C,Löffler B.-M,Brück W,Kamrowski-Kruck H,Gall S,Sirén A.-L,Schilling L

Publisher

Elsevier BV

Subject

General Neuroscience

Reference46 articles.

1. Endothelin binding to NG108-15 cells: evidence for conventional ETA and ETB receptor subtypes and super-high affinity binding components;Angelova;Cell. molec. Biol.,1996

2. The endothelin system and endothelin-converting enzyme in the brain: molecular and cellular studies;Barnes;Neurochem. Res.,1997

3. Growth factor activity of endothelin-1 in primary astrocytes mediated by adhesion-dependent and -independent pathways;Cazaubon;J. Neurosci.,1997

4. Interstitial deletion of the endothelin-B receptor gene in the spotting lethal (sl) rat;Ceccherini;Hum. molec. Genet.,1995

5. BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection;Clozel;Life Sci.,1993

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sovateltide (ILR-1620) Improves Motor Function and Reduces Hyperalgesia in a Rat Model of Spinal Cord Injury;Neurocritical Care;2024-03-05

2. Sovateltide (ILR-1620) improves motor function and reduces hyperalgesia in a rat model of spinal cord injury.;2023-10-31

3. Endothelin Receptors in Cerebrovascular Diseases;GPCRs as Therapeutic Targets;2022-09-16

4. Sovateltide Mediated Endothelin B Receptors Agonism and Curbing Neurological Disorders;International Journal of Molecular Sciences;2022-03-15

5. Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke;CNS Drugs;2021-01